RAWALPINDI: In a significant development for Ferozsons Laboratories Limited, the company has confirmed the election of its new board of directors during an Extraordinary General Meeting (EGM) held on July 3, 2026. The meeting, which took place both at Blue Lagoon, Masood Akhter Kiyani Road, Rawalpindi, and via video conferencing, saw the approval and adoption of critical resolutions that define the company's strategic direction for the coming years.

The EGM commenced with the confirmation of the minutes from the 69th Annual General Meeting held on October 25, 2025. Stakeholders approved the minutes, marking the formal acceptance of the previous meeting's resolutions and discussions.

A pivotal outcome of the meeting was the election of seven directors to the board. The individuals elected to serve a three-year term from July 7, 2026, include Mr. Osman Khalid Waheed, Mrs. Amna Piracha Khan, Mrs. Munize Azhar Peracha, Mr. Shahid Anwar, Mr. Arshad Saeed Husain, Mr. Suleman Ghani, and Dr. Parvez Kamal Khan. This leadership team is expected to guide the company through its forthcoming ventures and expansions.

According to information available from the Pakistan Stock Exchange (PSX), the pharmaceutical sector in which Ferozsons Laboratories operates falls within the designated market category. This categorization is crucial for stakeholders and potential investors who track the company's performance and strategic decisions.

This election is anticipated to bring renewed focus and vigor as the newly appointed directors assume their roles. The company remains poised to continue its trajectory of growth and innovation within the pharmaceutical industry, supported by a leadership team with diverse expertise and experience.